26.08.2015 • News

Monsanto Raises Bid for Syngenta

It was surely only a matter of time before leading agrochemicals company Monsanto increased its offer again for Swiss rival Syngenta. The company is reported to have raised its bid to around $46 billion, or 470 Swiss francs per share. The break-up fee, payable should the deal fail to receive regulatory approval, was also increased from $2 billion to $3 billion.

Syngenta turned down Monsanto’s previous offers in April and May, both of which valued its shares at 449 Swiss francs. Reports say Syngenta is expected to reject this third bid too as the offer remains well below what it regards as fair value.

A survey of nearly 100 current and former Syngenta shareholders by Bernstein Research earlier this month found that 92% were in favor of a negotiated deal and most of them would accept an offer 5% higher.

Both companies have declined to comment.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.